Bank Of America Corp Pliant Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 604,245 shares of PLRX stock, worth $9.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

604,245

Previous 497,814 21.38%

Holding current value

$9.06 Million

Previous $7.42 Million 12.43%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $1.13 Million - $1.66 Million	106,431 Added 21.38%	604,245 $6.5 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $5.93 Million - $8.22 Million	419,484 Added 535.53%	497,814 $7.42 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $281,299 - $419,212	-21,891 Reduced 21.84%	78,330 $1.42 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $429,425 - $724,241	23,699 Added 30.97%	100,221 $1.82 Million
Q1 2023 May 12, 2023	BUY	$18.73 - $36.26 $1.03 Million - $2 Million	55,221 Added 259.24%	76,522 $2.04 Million
Q4 2022 Feb 10, 2023	SELL	$17.0 - $25.43 $833,952 - $1.25 Million	-49,056 Reduced 69.72%	21,301 $411,000
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $434,566 - $1.37 Million	56,658 Added 413.59%	70,357 $1.47 Million
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $17,003 - $36,198	-4,137 Reduced 23.19%	13,699 $109,000
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $56,360 - $113,364	-8,040 Reduced 31.07%	17,836 $125,000
Q4 2021 Feb 08, 2022	BUY	$12.27 - $18.26 $79,362 - $118,105	6,468 Added 33.33%	25,876 $350,000
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $177,720 - $312,520	10,784 Added 125.05%	19,408 $327,000
Q2 2021 Sep 13, 2021	BUY	$28.05 - $37.69 $241,903 - $325,038	8,624 New	8,624 $251,000

Others Institutions Holding PLRX

# of Institutions

165

Shares Held

64.1M

Call Options Held

481K

Put Options Held

105K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $730M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Pliant Therapeutics, Inc. Transaction History